Esreboxetine clinical trials
Also written SS-RBX.
Includes 1 study of Esreboxetine succinate.
How each study uses esreboxetine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the esreboxetine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses esreboxetine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research DesignRecruitingPhase 3Axsome Therapeutics, Inc.NCT07398417Written as AXS-14 (Esreboxetine)
- Open-Label Safety Study of AXS-14 in Subjects With FibromyalgiaEnrolling by invitationPhase 3Axsome Therapeutics, Inc.NCT07637162Written as AXS-14 (esreboxetine)
- Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.WithdrawnPhase 2PfizerNCT00562055Written as PNU-165442G; [S,S]-reboxetine
- A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.CompletedPhase 2PfizerNCT00752505Written as Esreboxetine
- Maintenance of Efficacy.WithdrawnPhase 3PfizerNCT00796601Written as Esreboxetine
- Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.CompletedPhase 2PfizerNCT00141128Written as SS-RBX
- Phase 1 Thorough QT (TQT) Study in Young Healthy VolunteersCompletedPhase 1PfizerNCT00809289Written as esreboxetine
- An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.CompletedPhase 2PfizerNCT00138749Written as SS-RBX
- Phase I Study to Determine the Absorption, Distribution, Metabolism and Excretion of EsreboxetineCompletedPhase 1PfizerNCT00800956Written as [14C]-esreboxetine
Codes
What other systems call esreboxetine · ClinicalTrials.gg INT005448
- MeSH (NLM) C541385esreboxetineConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) L8S50ZY490ESREBOXETINEConfirmed FDA, NLM, Wikidata
- Wikidata Q5399299esreboxetineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C175719EsreboxetineOne source FDA
- DrugBank DB12395One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C541385 | esreboxetine | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | L8S50ZY490 | ESREBOXETINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5399299 | esreboxetine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C175719 | Esreboxetine | One source FDA |
| DrugBank | DB12395 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.